Suppr超能文献

Where will the (New) Drugs for Traumatic Brain Injury Treatment be Coming From?

作者信息

Agoston Denes V, Risling Mårten

机构信息

Experimental Traumatology, Department of Neuroscience, Karolinska Institutet Stockholm, Sweden.

出版信息

Front Neurol. 2012 Mar 2;3:27. doi: 10.3389/fneur.2012.00027. eCollection 2012.

Abstract
摘要

相似文献

1
Where will the (New) Drugs for Traumatic Brain Injury Treatment be Coming From?
Front Neurol. 2012 Mar 2;3:27. doi: 10.3389/fneur.2012.00027. eCollection 2012.
2
[Mild traumatic brain injury and postconcussive syndrome: a re-emergent questioning].
Encephale. 2012 Sep;38(4):329-35. doi: 10.1016/j.encep.2011.07.003. Epub 2011 Aug 31.
3
Blood-brain barrier pathophysiology in traumatic brain injury.
Transl Stroke Res. 2011 Dec;2(4):492-516. doi: 10.1007/s12975-011-0125-x.
4
Oculomotor, Vestibular, and Reaction Time Tests in Mild Traumatic Brain Injury.
PLoS One. 2016 Sep 21;11(9):e0162168. doi: 10.1371/journal.pone.0162168. eCollection 2016.
8
[Effect of Antithrombotic Drugs Reversal on Geriatric Traumatic Brain Injury].
No Shinkei Geka. 2020 Jun;48(6):497-504. doi: 10.11477/mf.1436204218.
9
Common psychiatric syndromes and pharmacologic treatments of traumatic brain injury.
Curr Psychiatry Rep. 2000 Jun;2(3):268-73. doi: 10.1007/s11920-996-0021-3.
10
Anti-epileptic drugs in pediatric traumatic brain injury.
Expert Rev Neurother. 2016 Oct;16(10):1229-34. doi: 10.1080/14737175.2016.1200974. Epub 2016 Jun 23.

引用本文的文献

1
Fluid-Based Protein Biomarkers in Traumatic Brain Injury: The View from the Bedside.
Int J Mol Sci. 2023 Nov 13;24(22):16267. doi: 10.3390/ijms242216267.
2
Big Data in traumatic brain injury; promise and challenges.
Concussion. 2017 Jul 10;2(4):CNC45. doi: 10.2217/cnc-2016-0013. eCollection 2017 Dec.
3
The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes.
Neuropharmacology. 2017 Jul 1;120:11-19. doi: 10.1016/j.neuropharm.2016.03.021. Epub 2016 Mar 12.

本文引用的文献

1
2
The productivity crisis in pharmaceutical R&D.
Nat Rev Drug Discov. 2011 Jun;10(6):428-38. doi: 10.1038/nrd3405.
3
Perestroika in pharma: evolution or revolution in drug development?
Mt Sinai J Med. 2010 Jul-Aug;77(4):327-32. doi: 10.1002/msj.20198.
4
The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science.
Clin Pharmacol Ther. 2010 May;87(5):530-3. doi: 10.1038/clpt.2010.27.
5
Precompetitive research: a new prescription for drug development?
Clin Pharmacol Ther. 2010 May;87(5):521-3. doi: 10.1038/clpt.2010.28.
6
Financial anatomy of neuroscience research.
Ann Neurol. 2006 Dec;60(6):652-9. doi: 10.1002/ana.21047.
7
An audience with... Francis S. Collins [interview].
Nat Rev Drug Discov. 2004 Aug;3(8):640. doi: 10.1038/nrd1488.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验